Abstract
The disease COVID-19 caused by SARS-CoV-2 that led to serious health problems since late 2019, and WHO announced as pandemic. The only diagnostic strategy available during pandemic was RT PCR used as the gold standard method, due to its high throughput procedure and high cost, the screening of patients would be difficult. Hence the antigen and antibody detecting rapid diagnostic kits were developed, that can be used as the point of care testing. The assessment of iFInDx COVID-19 IgM/IgG test kit was evaluated the sensitivity and specificity of the diagnostic kit with a total samples of 427 compared with ELISA and RT PCR method.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: IP International Journal of Medical Microbiology and Tropical Diseases
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
